Entry Detail



General Information

Database ID:exR0000289
RNA Name:ADCY6
RNA Type:mRNA
Chromosome:chr12
Starnd:-
Coordinate:
Start Site(bp):48766194End Site(bp):48789037
External Links:ENSG00000174233



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
MACF1
chr1
39081316
39487177
+
SLC25A29
chr14
100291116
100306547
-
HSP90AB1
chr6
44246166
44253888
+
CALM1
chr14
90396502
90408268
+
PRRT4
chr7
128350325
128361685
-
LCMT1
chr16
25111731
25178231
+
FLNA
chrX
154348524
154374638
-
TPM4
chr19
16067021
16103002
+
FADS2
chr11
61792980
61867354
+
MYBBP1A
chr17
4538897
4555631
-
UBB
chr17
16380798
16382745
+
RNF167
chr17
4940008
4945222
+
PUS1
chr12
131929200
131945896
+
LRCH4
chr7
100574011
100586129
-
SELENOP
chr5
42799880
42887392
-
ARID1A
chr1
26693236
26782104
+
PEX19
chr1
160276812
160286348
-
IGF2
chr11
2129112
2141238
-
FNDC3B
chr3
172039578
172401669
+
HUWE1
chrX
53532096
53686728
-
PDCD7
chr15
65117379
65133808
-
LENG8
chr19
54448887
54462037
+
SYNM
chr15
99098217
99135593
+
EME2
chr16
1772810
1781708
+
FNTB
chr14
64986895
65062652
+
SMARCD1
chr12
50085200
50100707
+
SNTB2
chr16
69187129
69309052
+
ZNF628
chr19
55476617
55484487
+
SNRPF
chr12
95858928
95903828
+
TAZ
chrX
154411524
154421726
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC069281.2
chr7
100572232
100578700
-
AC138761.1
chr17
22266395
22288301
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.